Cancer / Oncology
Breast Cancer in 2025 : Dr. Ramjee Bastola , NEPAL
Breast Cancer in 2025: Advancements, Challenges, and Hope Breast cancer remains one of the most common and widely recognized forms of cancer globally, particularly among women. Despite major progress in prevention, early detection, and treatment, it continues to pose a significant health burden. As of 2025, breast cancer research and clinical care are experiencing rapid…
HER2-Positive Breast Cancer Treatment
The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved to be used to prevent a relapse in patients with early-stage HER2-positive breast cancer. Pertuzumab (Perjeta) is used to treat metastatic HER2-positive breast cancer, and also both before surgery (neoadjuvant) and after surgery (adjuvant therapy). Trastuzumab and pertuzumab together can be used…
Targeted therapy
Targeted therapy is a type of cancer treatment that works differently to chemotherapy. Chemotherapy attacks all rapidly dividing cells in the body, but targeted therapy works by “targeting” those differences that help a cancer cell to survive and grow. Targeted treatments can be taken orally, injected or given intravenously (through a vein). They may be given…
Treatment of breast cancer
Treatments are less invasive when breast cancer is detected at an early stage. Challenges for breast cancer treatment in Nepal include patient’s financial status (given the huge out-of-pocket expenditure), accessibility and availability of health services and infrastructures, etc. Several modalities of treatment are currently available for breast cancer patients as following: Surgery: Many breast cancer…